Advisory Solutions Group, LLC’s AbbVie ABBV Stock Holding History

Advisory Solutions Group, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$839K	Buy	+3,333	New	+$717K	0.28%	79

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Advisory Solutions Group, LLC's ABBV Position: Q2 2026 in Review

Advisory Solutions Group, LLC opened a new position in AbbVie (ABBV) in Q2 2026: 3,333 shares worth $839K. The stake represents 0.28% of the portfolio and ranks #79 among its holdings.

1,899 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Advisory Solutions Group, LLC held 3,333 shares of AbbVie worth $839K as of Q2 2026.
AbbVie was a new Advisory Solutions Group, LLC position in Q2 2026.
AbbVie made up 0.28% of Advisory Solutions Group, LLC's portfolio in Q2 2026, its #79 holding.
1,899 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advisory Solutions Group, LLC's 13F filing for Q2 2026, filed 29 Jul 2026.